Skip to content

Author

Torrance Teng

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Evaluating taletrectinib in the treatment of patients with ROS1 fusion-positive non–small cell lung cancer

ABSTRACT ROS1 fusion-positive non–small cell lung cancer (NSCLC), occurring in 1–2% of patients, represents a rare but clinically important subset. Patients with ROS1 fusion-positive NSCLC are often younger and tend to have little or no history of smoking. Current first-generation tyrosine kinase inhibitors (TKIs) such...

M. Nagasaka, C. Park, Z. Arter et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.